-+ 0.00%
-+ 0.00%
-+ 0.00%

NEKTAR TO HOLD CONFERENCE CALL TO DISCUSS TOPLINE RESULTS FROM THE 36-WEEK MAINTENANCE PERIOD FOR ITS REZOLVE-AD PHASE 2B STUDY OF REZPEGALDESLEUKIN IN ATOPIC DERMATITIS ON FEBRUARY 10, 2026

Reuters·02/09/2026 21:15:00

Please log in to view news